Advertisements



Viking Therapeutics: Partnerships, Abstracts, And Endpoints

Viking Therapeutics: Partnerships, Abstracts, And Endpoints.....»»

Category: topSource: seekingalphaNov 9th, 2018

Viking Therapeutics says VK2809 study achieves primary, secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

Viking Shares Jump After Fatty Liver Drug Meets Midstage Trial Endpoints

Viking Therapeutics Inc (NASDAQ: VKTX) shares have raced away Tuesday following the read more.....»»

Category: blogSource: benzingaSep 18th, 2018

Sage Therapeutics: SAGE-217 meets primary, secondary endpoints in Phase 3 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

Viking Therapeutics reiterated as buy at SunTrust Robinson Humphrey

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchDec 31st, 2018

Why Viking Therapeutics Sank Today

A market sell-off caused the clinical-stage biotech stock to fall hard......»»

Category: topSource: foxnewsDec 27th, 2018

Oversold Conditions For Viking Therapeutics (VKTX)

Dividend Channel.....»»

Category: topSource: redinewsDec 27th, 2018

Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics

Both of these NASH stocks have what it takes to overcome a bear market, but which is the better pick now?.....»»

Category: topSource: foxnewsDec 26th, 2018

G1 Therapeutics stock dives on cancer-related infection drug study results

G1 Therapeutics Inc. shares dropped in the extended session Wednesday after the biotech drug maker said one of its drugs met endpoints i.....»»

Category: topSource: marketwatchDec 19th, 2018

Viking Therapeutics And VK2809 In NAFLD: Discerning The Scientific Misconceptions

Viking Therapeutics And VK2809 In NAFLD: Discerning The Scientific Misconceptions.....»»

Category: topSource: seekingalphaDec 19th, 2018

Commit To Purchase Viking Therapeutics At $5, Earn 30% Using Options

Investors eyeing a purcha.....»»

Category: futuresSource: nasdaqDec 18th, 2018

Commit To Purchase Viking Therapeutics At $5, Earn 30% Using Options

Stock Options Channel.....»»

Category: topSource: redinewsDec 18th, 2018

Viking Therapeutics initiated with a Buy at B. Riley FBR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 11th, 2018

Viking Therapeutics Won"t Live Up To The Hype

Viking Therapeutics Won"t Live Up To The Hype.....»»

Category: topSource: seekingalphaNov 26th, 2018

Viking Has A More Attractive M&A Valuation Than Madrigal, Raymond James Says In Upgrade

Viking Therapeutics Inc (NASDAQ: VKTX), which focuses on therapies for metabolic and endocrine disorders, recently presented Phase 2 data for its non-alcoholic fatty li Latest Ratings for V.....»»

Category: blogSource: benzingaNov 19th, 2018

Viking Therapeutics upgraded to Strong Buy at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Viking Therapeutics upgraded to Strong Buy from Outperform at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Why Viking Therapeutics Shares Are Finding Renewed Buying Interest

Viking Therapeutics Inc (NASDAQ: VKTX) shares — which cooled off following an 87-percent jump Sept. read more.....»»

Category: blogSource: benzingaNov 13th, 2018

Viking Therapeutics: Year In Review

Viking Therapeutics: Year In Review.....»»

Category: topSource: seekingalphaNov 13th, 2018

Viking Therapeutics data mitigates perceived safety risk, says William Blair

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2018

Viking Therapeutics Stock Sees Short Interest Jump 12.2%

Market News Video.....»»

Category: topSource: redinewsNov 12th, 2018